Target intelligence / Profile preview

DNA polymerase III (bacterial) (null)

Target
null
Molecular classification
Enzyme, DNA-directed DNA polymerase, Replication complex (includes also helicase, primase, single-strand binding protein, etc.)
01

Overview

DNA synthesis in bacteria refers to the process of chromosomal DNA replication, fundamental for bacterial cell division and survival. This process is executed by a multi-protein complex called the replisome, with DNA polymerase III as the central enzyme responsible for catalyzing the addition of deoxyribonucleotides to a growing DNA strand, using an existing strand as a template. DNA polymerase III is highly processive and accurate, with supporting proteins for initiation, strand separation (helicase), primer synthesis (primase), and topological control (DNA gyrase and topoisomerases). The inhibition of key proteins involved in DNA synthesis is a validated antibacterial strategy, although DNA polymerase III itself is not directly targeted by any clinical antibiotics due to selectivity challenges. Disruption of this machinery, or its auxiliary proteins, arrests bacterial proliferation, making components of the replisome attractive but technically challenging antibiotic targets[2][4][6][8].

Other names
DNA replication machinery (bacterial)Bacterial replisomeDNA polymerase III holoenzymePol IIIBacterial DNA replicase
02

Mechanism of action

Inhibition of DNA supercoiling and/or topoisomerase activity (prevents replication fork progression) Induction of DNA strand breaks Inhibition of associated proteins required for replisome formation and activity

03

Biological functions

DNA replicationCell proliferationGenomic integrity maintenanceInheritance of genetic information
04

Disease associations

Infection (essential for bacterial propagation and thus infection)
05

Safety considerations

Off-target effects can occur with DNA replication inhibitors if host (human) polymerases are inhibitedDevelopment of resistance (e.g., mutations in DNA gyrase with quinolones)Effects on commensal bacteria, gut microbiome disruption
06

Interacting drugs

Quinolones (e.g., ciprofloxacin, levofloxacin — inhibit DNA gyrase/topoisomerase, which are replisome-associated)

4 more in the full profile.

07

Biomarkers

Expression of replication machinery genes (e.g., dnaE, the gene encoding Pol III α subunit)DNA synthesis rate (measured by nucleotide analog incorporation in research)Proliferative index of bacteria in vitro

Beyond the preview

Go deeper on DNA polymerase III (bacterial) (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase III (bacterial) (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call